A detailed history of Dorsey & Whitney Trust CO LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dorsey & Whitney Trust CO LLC holds 10,080 shares of GILD stock, worth $887,846. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,080
Previous 12,613 20.08%
Holding current value
$887,846
Previous $923,000 25.14%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$63.15 - $72.88 $159,958 - $184,605
-2,533 Reduced 20.08%
10,080 $691,000
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $124,978 - $152,408
1,746 Added 16.07%
12,613 $923,000
Q4 2023

Feb 12, 2024

BUY
$73.27 - $83.09 $4,249 - $4,819
58 Added 0.54%
10,867 $880,000
Q3 2023

Nov 08, 2023

SELL
$73.94 - $80.67 $9,834 - $10,729
-133 Reduced 1.22%
10,809 $810,000
Q2 2023

Aug 10, 2023

BUY
$76.01 - $86.7 $4,788 - $5,462
63 Added 0.58%
10,942 $843,000
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $122,381 - $139,430
-1,583 Reduced 12.7%
10,879 $902,000
Q4 2022

Feb 09, 2023

BUY
$62.32 - $89.47 $11,092 - $15,925
178 Added 1.45%
12,462 $1.07 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $350,452 - $400,306
5,886 Added 92.0%
12,284 $759,000
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $20,836 - $23,468
361 Added 5.98%
6,398 $397,000
Q1 2022

May 11, 2022

SELL
$57.92 - $72.58 $4,517 - $5,661
-78 Reduced 1.28%
6,037 $359,000
Q4 2021

Feb 08, 2022

BUY
$64.88 - $73.64 $33,932 - $38,513
523 Added 9.35%
6,115 $443,000
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $7,648 - $8,252
113 Added 2.06%
5,592 $390,000
Q2 2021

Aug 11, 2021

SELL
$63.47 - $69.35 $61,121 - $66,784
-963 Reduced 14.95%
5,479 $376,000
Q1 2021

May 11, 2021

BUY
$60.0 - $68.46 $125,460 - $143,149
2,091 Added 48.06%
6,442 $416,000
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $152,105 - $173,316
-2,685 Reduced 38.16%
4,351 $253,000
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $58,684 - $73,785
-945 Reduced 11.84%
7,036 $443,000
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $154,879 - $179,844
-2,141 Reduced 21.15%
7,981 $614,000
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $118,495 - $151,776
-1,892 Reduced 15.75%
10,122 $757,000
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $56,443 - $62,086
916 Added 8.25%
12,014 $779,000
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $125,082 - $138,069
2,001 Added 22.0%
11,098 $703,000
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $139,578 - $156,521
-2,256 Reduced 19.87%
9,097 $616,000
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $17,883 - $20,034
286 Added 2.58%
11,353 $736,000
Q4 2018

Jan 25, 2019

BUY
$60.54 - $79.0 $156,616 - $204,373
2,587 Added 30.51%
11,067 $692,000
Q3 2018

Oct 26, 2018

BUY
$71.28 - $78.92 $58,592 - $64,872
822 Added 10.73%
8,480 $655,000
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $20,177 - $23,536
-311 Reduced 3.9%
7,658 $543,000
Q1 2018

May 08, 2018

SELL
$72.84 - $88.8 $81,362 - $99,189
-1,117 Reduced 12.29%
7,969 $602,000
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $118,820 - $139,478
-1,670 Reduced 15.53%
9,086 $652,000
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $775,615 - $919,315
10,756
10,756 $872,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Dorsey & Whitney Trust CO LLC Portfolio

Follow Dorsey & Whitney Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey & Whitney Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey & Whitney Trust CO LLC with notifications on news.